Enterprise Manufacturing — For Premium Brands

Enterprise-Grade Supplement

Scale-Up CDMO.

When your seven-figure marketing budget demands absolute batch-to-batch consistency, Olympia Biosciences™ delivers HPLC/GC-MS-verified Certificates of Analysis on every production run, PPQ-validated process qualification (Cpk >1.33), and ISO 22000/GMP-certified manufacturing — the supply-chain foundation that scaling premium brands demand.

Book a Facility Audit Explore Technology Stack ›

The Scale-Up Dilemma for Premium Supplement Brands

Scaling a premium supplement brand introduces existential risks that startups do not face. Your previous manufacturer's 500-unit pilot batch was perfect, but their 50,000-unit commercial run suffered from inconsistent blending. Or worse — your flagship product went out-of-stock during your biggest campaign because they failed to secure raw materials. Or the ultimate nightmare: an independent laboratory tested your product and found it contained 30% less active ingredient than the label claimed.

Olympia Biosciences™ operates as your external QA/QC and production engineering department. We mitigate supply chain risk through obsessive documentation, validated procedures, and pharmaceutical-grade analytics.

Industrial supplement production line — pharmaceutical-grade manufacturing

Full Traceability & CoA

Every raw material entering our quarantine warehouse is tested. Every finished batch leaving our facility is released with a comprehensive Certificate of Analysis (CoA). We use HPLC and GC-MS to verify the exact concentration of active compounds. No guessing. Just data.

Iron-Clad IP Protection

Your custom formulation is your company's valuation. We sign strict NDAs before you reveal your concept. Our ISO 27001 certified Information Security Management System ensures your proprietary data never leaks. And because we do not own consumer brands, we will never copy your success.

Branded Ingredients & Advanced Tech

We source and process patented, clinically-backed raw materials (e.g., KSM-66®, Verisol®, Cognizin®). We offer advanced delivery systems including liposomal encapsulation, nano-micellization, and enteric-coated (DRcaps) to protect sensitive compounds from gastric acid.

CAPA & GMP Compliance

Mistakes happen in manufacturing. The difference is how a CDMO responds. We operate under strict CAPA (Corrective and Preventive Action) procedures. Our facility maintains integrated HACCP, ISO 22000, ISO 9001, and GMP certifications audited by independent bodies.

Market Intelligence 2026

$178.82B

Global Medical-Grade Supplement Market Baseline (2023)

Currently in 2026, the global medical-grade supplement market continues its exponential expansion. Driven by a steady 8.8% annual growth rate from a $178.82 billion baseline in 2023, this upward trajectory is firmly projected to last through 2032, heavily favoring science-backed CDMO partnerships.

Do not trust our marketing. Trust your auditor.

We do not expect enterprise brands to sign contracts based on a website. We invite your QA director or independent auditor to our facility in Gdynia, Poland. Inspect our clean rooms. Review our batch records. Check our HEPA filtration logs. See the laboratory where your product will be tested.

Schedule Facility Tour Request Mutual NDA ›

Frequently Asked Questions

Does Olympia Biosciences™ sign NDAs before formulation discussions?
Yes. We execute strict, iron-clad Non-Disclosure Agreements (NDAs) before any technical discussions begin. Your intellectual property is further protected by our ISO 27001 certified Information Security Management System and our strict Zero Conflict of Interest policy.
Can we audit your manufacturing facility?
Absolutely. We welcome facility audits from our enterprise partners. You can inspect our clean rooms, QA/QC laboratories, quarantine warehouses, and review our CAPA (Corrective and Preventive Action) procedures in Gdynia, Poland.
Do you provide full traceability and Certificates of Analysis (CoA)?
Yes. We provide full traceability from raw material intake to finished product. Every batch is released with a comprehensive Certificate of Analysis (CoA) verified by HPLC and GC-MS testing to confirm the exact active compound content.
What is PPQ validation and why does it matter for supplement scale-up?
Process Performance Qualification (PPQ) is a pharmaceutical-grade validation protocol that confirms a manufacturing process consistently produces product meeting all quality specifications at commercial scale. We validate all scale-up projects to Cpk greater than 1.33, meaning our processes operate at a Six Sigma level of consistency. This ensures every production run exactly replicates your validated formula — critical for brands maintaining premium positioning.
What production volumes can Olympia Biosciences™ handle for supplement contract manufacturing?
We handle production volumes from 5,000 units (physician start-up brands) to 100M+ capsules per month (enterprise scale). Our three independent softgel encapsulation lines provide 300% technical redundancy. We have no production bottlenecks — you can scale from a pilot batch to full industrial production within the same validated facility and team.
What is the difference between a pilot batch and a production batch at Olympia Biosciences™?
A pilot batch (Proof of Concept) is a small-scale production run — typically 5,000–50,000 units — used to validate your formula at manufacturing scale before committing to full production. It confirms formula stability, processability, and analytical parameters. Once the PoC is approved, we perform validated scale-up to production quantities using our PPQ protocol, guaranteeing batch-to-batch consistency across all production runs.

Strictly B2B / Educational R&D Disclaimer

The pharmacokinetic data, clinical references, and scientific literature referenced on this page are provided strictly for B2B formulation, educational, and R&D purposes for medical professionals, pharmacologists, and brand developers. Olympia Biosciences™ operates solely as a Contract Development and Manufacturing Organization (CDMO) and does not manufacture, market, or sell consumer end-products.

Global Regulatory & No Health Claims. Nothing on this page constitutes a health claim, medical claim, or disease-risk-reduction claim within the meaning of EU Regulation (EC) No 1924/2006, the U.S. Dietary Supplement Health and Education Act (DSHEA), or other global regulatory frameworks. These statements and raw data have not been evaluated by the Food and Drug Administration (FDA), European Food Safety Authority (EFSA), or Therapeutic Goods Administration (TGA). The raw active pharmaceutical ingredients (APIs) and formulations discussed are not intended to diagnose, treat, cure, or prevent any disease.

Client Responsibility. The B2B client who commissions a formulation from Olympia Biosciences™ bears full and sole responsibility for all regulatory compliance, health claim authorization (including EFSA Article 13/14 claim dossiers and U.S. FDA notifications), labeling, and marketing of their finished product in their target market(s). Olympia Biosciences™ provides manufacturing, formulation, and analytical services only.